(Q55440645)

10 July 2018

title

Prolonged remission maintenance in acute myeloid leukaemia. (English)

1 reference

10 July 2018

1 reference

3

Catovsky D

1 reference

10 July 2018

Spiers AS

1

1 reference

10 July 2018

Goldman JM

2

1 reference

10 July 2018

Costello C

4

1 reference

10 July 2018

Galton DA

5

1 reference

10 July 2018

Pitcher CS

6

1 reference

10 July 2018

language of work or name

English

0 references

publication date

1 August 1977

1 reference

10 July 2018

number of pages

4

1 reference

inferred from page(s)

published in

The BMJ

1 reference

10 July 2018

volume

2

1 reference

10 July 2018

issue

6086

1 reference

10 July 2018

page(s)

544-547

1 reference

10 July 2018

Developmental therapy in adult acute leukemia

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1631479

Immunotherapy for acute myelogenous leukaemia: a controlled clinical study 2 1/2 years after entry of the last patient

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1631479

Quality and quantity of survival in acute myeloid leukaemia

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1631479

Factors effecting remission and survival in adult acute nonlymphocytic leukemia (ANLL).

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1631479

Drug dosage and remission duration in childhood lymphocytic leukemia

12 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1631479

Combination Chemotherapy using L-Asparaginase, Daunorubicin, and Cytosine Arabinoside in Adults with Acute Myelogenous Leukaemia

12 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1631479

Management of adult acute myelogenous leukaemia.

12 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1631479

Acute myelocytic leukemia in adults.

12 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1631479

Adult acute leukemia. The Rochester (NY) Experience

12 August 2018

1 reference

12 December 2020

Chemoimmunotherapy of adult acute leukaemia. Prolongation of remission in myeloblastic leukaemia with B.C.G.

1 reference

12 December 2020

Daunorubicin in the treatment of acute myelocytic leukaemia

1 reference

12 December 2020

Treatment of the acute leukemias

1 reference

12 December 2020

Five-year follow-up of "total therapy" of childhood lymphocytic leukemia

1 reference

12 December 2020

Cytosine arabinoside in acute granulocytic leukemia

1 reference

12 December 2020

Treatment of acute leukemia in adults

1 reference

12 December 2020

Identifiers

DOI

10.1136/BMJ.2.6086.544

1 reference

10 July 2018

PMC publication ID

1631479

1 reference

10 July 2018

PubMed publication ID

268229

1 reference

10 July 2018